SCHEMBL11168905

SCHEMBL11168905

Cc1ccc(Sc2c(O)c(O)cc3c2CCN(C)CC3)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRNP P04156 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ DRD1 P21728 7/20 0.38
▸ DRD2 P14416 5/20 0.38
▸ DRD5 P21918 5/20 0.38
▸ DRD4 P21917 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ADRA2A P08913 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ PMP22 Q01453 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ THPO P40225 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11215258 0.90 DRD2 (0.42) DRD1DRD2DRD5DRD4DRD3
SCHEMBL11216598 0.88 DRD2 (0.41) DRD1DRD2DRD5DRD4KDM4E
SCHEMBL11162257 0.88 PTPN2 (0.38) DRD1DRD2DRD5DRD4DRD3
SCHEMBL10471907 0.88 DRD1 (0.44) DRD1DRD2DRD5DRD4KDM4E
Bromide SCHEMBL11159318 0.86 DRD1 (0.47) DRD1DRD2DRD5DRD4KDM4E
SCHEMBL11216603 0.86 DRD1 (0.43) DRD1DRD2DRD5DRD4MEN1
SCHEMBL11155830 0.85 KDM4E (0.38) DRD1DRD2DRD5DRD4KDM4E
SCHEMBL11167334 0.83 ALDH1A1 (0.40) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL11214820 0.82 DRD2 (0.36) DRD1DRD2DRD5DRD4DRD3
Fumaric Acid SCHEMBL11380659 0.78 SMN1; SMN2 (0.39) DRD1DRD2DRD5KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0080012-A1 6-Chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its acid addition salts and its use as an intermediate SMITHKLINE BECKMAN CORPORATION (US) 1983-06-01 — — EP disclosed
EP-0007070-B1 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS HAVING DOPAMINE RECEPTOR BLOCKING ACTIVITY SMITHKLINE BECKMAN CORPORATION (US) 1983-01-19 — — EP disclosed
US-4265890-A ANTIPSYCHOTIC, ANTIEMETICS SMITHKLINE CORPORATION (US) 1981-05-05 — — US disclosed
EP-0007070-A1 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity SMITHKLINE BECKMAN CORPORATION (US) 1980-01-23 — — EP disclosed
Send feedback